The ZNF703-ASOs were evaluated by WB for their capacity to repress both endogenous and exogenous ZNF703 (ZNF703 and ZNF703/GFP) protein expression in MCF7-ZNF703/GFP BC cells at 100 nM concentration (Figure S1B and Figure 2). The gene discussed is ZNF703; the disease is breast cancer.